Percutaneous coronary intervention
Transform complex PCI procedures into confident care
Demonstrated results
28.8%
reduction in contrast agent with Dynamic Coronary Roadmap2.
Clinical Study: Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial.
85%
of users believe the Azurion TSM control of HEMO visualizations & measurements improves workflow5.
$896
saved per patient with Philips iFR compared to FFR3.
Featured products for percutaneous coronary intervention
Azurion 7 M12 - the heart of our solution for cardiac care
Proven to reduce procedure time by 17%1 by experiencing the outstanding performance of the Azurion 7 M12. This industry-leading image-guided solution supports better patient care and operational efficiency with seamless control from a single tableside touch screen for fast, informed decisions in the sterile field.
Dynamic Coronary Roadmap - find your path
Find the right path and improve PCI outcomes. Dynamic Coronary Roadmap, a Philips-exclusive solution, offers motion-compensated, real-time navigational guidance of coronary arteries and reduces contrast agent by 28.8%.2
Hemo with IntelliVue X3 - monitor anywhere
Improve productivity to meet growing demand for cath lab procedures. This solution simplifies workflow by bringing advanced hemodynamic measurements to the cath lab. Integrated with the IntelliVue X3 patient monitor, it enables continuous patient monitoring throughout the cath lab.
IntraSight
Philips IntraSight offers you a comprehensive suite of clinically proven6-10 imaging, physiology and co-registration11 tools on a modern, secure platform that will help you simplify complex interventions, speed routine procedures and improve lab efficiencies.
“Dynamic Coronary Roadmap is a great asset to add to the interventional toolkit. It is an easy to use tool which reduces the contrast exposure to patients. It is very useful in patients with low GFR or patients with branch vessel disease. I use it very frequently to assist in decreasing contrast use. “
Dr. Strobel,
Interventional Cardiologist
Baptist Health, Little Rock, US
Documentation
Related procedures
-
Explore Philips’ TAVI and TAVR solutions, providing exceptional imaging and optimized processes for effective structural heart disease treatments.
-
Optimize LAAO procedures with Philips imaging technology, for precise device placement and streamlined workflows.
-
Elevate transcatheter mitral and tricuspid therapies with Philips’ imaging solutions, achieving accurate device placement and enhanced procedural efficiency.
-
![Cardiac surgery in the Hybrid OR]()
Our leading imaging systems, advanced clinical tools and devices enable surgeons as they decide, guide, treat, and confirm results.
-
When every moment counts, give them every chance with minimally invasive congenital heart disease interventions.
Technologies and innovations
-
Image-guided therapy solutions portfolio integrates best in class imaging systems and software, with diagnostic and therapeutic devices to support complex procedures.
-
Learn how Philips intravascular ultrasound (IVUS) imaging offers advanced visualization that enables you to tailor your treatment for every patient.
-
![Clinically proven Azurion with ClarityIQ technology]()
Providing superb image quality at ultra-low dose settings.
-
Philips Azurion is the next generation image-guided therapy platform with a unique user experience to help you optimize the performance of your cath lab.
Footnotes
[1] Philips whitepaper 12nc 4522 991 30501; Reduction of procedure time by 17% with Philips Azurion in independently verified study; . Results are specific to the institution where they were obtained and may www.philips.com/ healthcare/resources/landing/azurion/lab-performance-study-results not reflect the results achievable at other institutions. [2] Clinical Study: Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial. [3] Gotberg M, et al. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. Int J Cardiol 2021 1;344:54-59. [4] Co-registration tools available within InstraSight 7 configuration via SyncVision. [5] Results obtained during usability study performed in December 2016. The study involved 33 participants. Participants were spread evenly over technologist/ nurses and physicians. To evaluate benefits of the multi-user capabilities of the new system design and user satisfaction, its novel design was tested by participants that had relevant working experience in the interventional lab and who had not previously used the new system. Data on File. [6] Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017. [7] Gotberg M, et al., Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial. New England Journal of Medicine, epub March 18, 2017. [8] Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018. [9] A. Maehara, M. Matsumura, Z.A. Ali, G.S. Mintz, G.W. Stone. IVUS-guided versus OCT-guided coronary stent implantation. J Am Coll Cardiol Img, 10 (2017), pp. 1487- 1503. [10] Choi K, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing [11] Co-registration tools available within IntraSight 7 configuration via SyncVision ©2024 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners. Philips reserves the right to change product specifications without prior notification.
Always read the label and follow the directions for use.Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.Products subject to country availability. Please contact your local sales representative.
